SDS

Reactivity
None under normal use conditions.
Stability
Stable under normal conditions.
Hazardous polymerization
Hazardous polymerization does not occur.
Hazardous Reactions
None under normal processing.
Conditions to Avoid
None under normal processing.
Materials to avoid
None in particular.
Hazardous Decomposition Products
None under normal use.
11. TOXICOLOGICAL INFORMATION
Product Information
Information on likely routes of exposure
Inhalation
No known effect.
Skin contact
Irritating to skin.
Ingestion
No known effect.
Eye contact
Causes serious eye irritation.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Acute toxicity
No known effect.
Skin corrosion/irritation
Irritating to skin.
Serious eye damage/eye irritation
Causes serious eye irritation.
Skin sensitization
No known effect.
Respiratory sensitization
No known effect.
Germ cell mutagenicity
No known effect.
Neurological Effects
No known effect.
Reproductive toxicity
No known effect.
Developmental toxicity
No known effect.
Teratogenicity
No known effect.
STOT - single exposure
No known effect.
STOT - repeated exposure
No known effect.
Target Organ Effects
No known effect.
Aspiration hazard
No known effect.
Carcinogenicity
No known effect.
Component Information
Chemical Name CAS-No LD50 Oral LD50 Dermal LC50 Inhalation
Sodium carbonate 497-19-8 2800 mg/kg bw > 2000 mg/kg bw (US EPA
16 CFR 1500.40)
-
Benzenesulfonic acid,
mono-C10-16-alkyl derivs., sodium
salts
68081-81-2 1090.00 mg/kg (rat) - -
Silicic acid, sodium salt 1344-09-8 3400 mg/kg bw (Similar to
OECD 401; standard acute
method; rat)
> 5000 mg/kg bw (Read
across data on AgSil TM
25 Potassium silicate
solution; rat)
> 2.06 mg/L air (Read
across data AgSil TM 25
Potassium silicate solution;
EPA OPPTS 870.1300;
standard acute method;
rat)
12. ECOLOGICAL INFORMATION
Ecotoxicity
The product is not expected to be hazardous to the environment.
Page 5 / 7
96733749_RET_NG - Ariel Basico Revision Date: 17-Apr-2015